Sfoglia per Autore
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma
2002-01-01 Galimberti, Sara; Marasca, R; Caracciolo, F; Fazzi, R; Papineschi, Federico; Benedetti, E; Guerrini, Francesca; Morabito, F; Oliva, E; DI RENZO, N; Federico, M; Petrini, Mario; Torelli, G.
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab
2003-01-01 Galimberti, Sara; Guerrini, Francesca; Morabito, F; Palumbo, Ga; DI RAIMONDO, F; Papineschi, Federico; Caracciolo, F; Fazzi, R; Cervetti, G; Cuzzocrea, A; Petrini, Mario
IN VIVO PURGING WITH HYPER-CVAD PLUS RITUXIMAB IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA.
2004-01-01 Benedetti, E; Papineschi, Federico; Caracciolo, F; Galimberti, Sara; Cervetti, G; Castiglioni, G; Mechelli, S; Scatena, P; Pelosini, M; Petrini, Mario
ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOLLOWING A NON-MYELOABLATIVE (NMST) CONDITIONING WITH FLUDARABINE AND LOW DOSE TBI IN PATIENTS WITH HEMATOLOCICAL MALIGNANCIES AND METASTATIC MELANOMA: A SINGLE-CENTER EXPERIENCE.
2004-01-01 Benedetti, E; Papineschi, Federico; Caracciolo, F; Galimberti, Sara; Azzarà, A; Carulli, Giovanni; Petrini, Mario
Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with Imatinib
2004-01-01 Cervetti, G; Galimberti, Sara; Fazzi, R; Papineschi, Federico; Azzara', Antonio; Simi, P; Petrini, Mario
A myeloablative allograft after rejection of two consecutive nonmyeloablative transplants from two different HLA identical siblings
2004-01-01 Papineschi, Federico; Benedetti, E; Galimberti, Sara; Caracciolo, F; Fazzi, R; Petrini, Mario
Infliximab treatment of grade IV skin acute graft versus host disease
2005-01-01 Benedetti, E; Papineschi, Federico; Caracciolo, F; Carulli, Giovanni; Azzara', Antonio; Buda, G; Petrini, Mario
GAMMA-DELTA T-LYMPHOCYTE SPECIFIC CLONES ARE INVOLVED IN THE GRAFT-VERSUS-MYELOMA AND IN THE GRAFT-VERSUS-HOST DISEASE IN MULTIPLE MYELOMA PATIENTS AFTER NON-MYELOABLATIVE TRANSPLANTATION.
2005-01-01 Galimberti, Sara; Benedetti, E; Morabito, F; Battolla, B; Petrini, Iacopo; Papineschi, Federico; Martino, M; Console, G; Iacopino, P; Petrini, Mario
In Vivo Purging with Hyper-CVAD Plus Rituximab Followed by Autologous Stem Cells Transplant and Rituximab Maintenance in Newly Diagnosed Mantle Cell Lymphoma: A Pilot Study for GISL (Italian Cooperative Study Group for Lymphoma).
2005-01-01 Benedetti, E; Caracciolo, F; Galimberti, Sara; Papineschi, Federico; Pelosini, M; Cervetti, G; Castiglioni, Mg; Mechelli, S; Scatena, P; Brugiatelli, M; Petrini, Mario
Gentuzumab ozogamicin plus Flang (My-Flang) in refractory/relapsed acute myeloid leukaemias patients and pre-allogenic stem cell transplant
2005-01-01 Benedetti, E; Caracciolo, F; Papineschi, Federico; Pelosini, M; Andreazzoli, F; Azzara', Antonio; Carulli, Giovanni; Petrini, Mario
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life
2005-01-01 Saccardi, R; Mancardi, Gl; Solari, A; Bosi, A; Bruzzi, P; DI BARTOLOMEO, P; Donelli, A; Filippi, M; Guerrasio, A; Gualandi, F; LA NASA, G; Murialdo, A; Pagliai, F; Papineschi, Federico; Scappini, B; Marmont, Am
IN VIVO PURGING WITH HYPER-CAVD PLUS RITUXIMAB FOLLOWED BY AUTOLOGOUS TRANSPLANTATION AND RITUXIMAB MAINTENANCE IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA.
2005-01-01 Benedetti, E; Caracciolo, F; Papineschi, Federico; Galimberti, Sara; Pelosini, M; Castiglioni, Mg; Mechelli, S; Scatena, P; Petrini, Mario
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation
2005-01-01 Galimberti, Sara; Benedetti, E; Morabito, F; Papineschi, Federico; Callea, V; Fazzi, R; Stelitano, C; Andreazzoli, F; Guerrini, Francesca; Ciabatti, Elena; Martino, M; Nobile, F; Iacopino, P; Petrini, Mario
Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications
2005-01-01 Bonadio, M; Morelli, Girolamo; Mori, S; Riccioni, R; Papineschi, Federico; Petrini, Mario
Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation
2006-01-01 Galimberti, Sara; Benedetti, E; Morabito, F; Petrini, Iacopo; Battolla, B; Papineschi, Federico; Fazzi, R; Ciabatti, Elena; Martino, M; Cuzzola, M; Console, G; Iacopino, P; Petrini, Mario
Simultaneous appearance of acute myeloid leukemia in a patient with bilateral primary uveal melanoma
2006-01-01 Buda, Gabriele; Romagnoli, Mc; Galimberti, Sara; Figus, M; Papineschi, Federico; Nardi, Marco; Petrini, Mario
Granulocytic sarcoma and subsequent acute leukemia recurrence with different biologic characteristics 5 years after allogeneic bone marrow transplantation for acute myeloid leukemia
2006-01-01 Pelosini, M; Benedetti, E; Galimberti, Sara; Caracciolo, F; Petrini, Mario; Fazzi, R; Andreazzoli, F; Papineschi, Federico
Central nervous system graft-versus-host disease: consider progressive multifocal leukoencephalopathy among the differential diagnoses
2007-01-01 Focosi, D; Kast, Re; Maggi, F; Galimberti, Sara; Papineschi, Federico; Petrini, Mario; CECCHERINI-NELLI, Luca
Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemia
2007-01-01 Buda, G; Orciuolo, E; Galimberti, Sara; Benedetti, E; Caracciolo, F; Cervetti, G; Carulli, Giovanni; Papineschi, Federico; Petrini, Mario
EFFICACY OF FLUDARABINE, CYCLOPHOSPHAMIDE, RITUXIMAB (FCR) REGIMEN FOL- LOWED BY ALEMTUZUMAB AS IN VIVO PURGING TOOL FOR PATIENTS WITH ADVANCED CHRONIC LYMPHOCYTIC LEUKEMIA
2007-01-01 Galimberti, Sara; Cecconi, N; Cervetti, G; Caracciolo, F; Benedetti, E; Pelosini, M; Buda, G; Orciuolo, E; Papineschi, Federico; Petrini, Mario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma | 1-gen-2002 | Galimberti, Sara; Marasca, R; Caracciolo, F; Fazzi, R; Papineschi, Federico; Benedetti, E; Guerrini, Francesca; Morabito, F; Oliva, E; DI RENZO, N; Federico, M; Petrini, Mario; Torelli, G. | |
| Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab | 1-gen-2003 | Galimberti, Sara; Guerrini, Francesca; Morabito, F; Palumbo, Ga; DI RAIMONDO, F; Papineschi, Federico; Caracciolo, F; Fazzi, R; Cervetti, G; Cuzzocrea, A; Petrini, Mario | |
| IN VIVO PURGING WITH HYPER-CVAD PLUS RITUXIMAB IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA. | 1-gen-2004 | Benedetti, E; Papineschi, Federico; Caracciolo, F; Galimberti, Sara; Cervetti, G; Castiglioni, G; Mechelli, S; Scatena, P; Pelosini, M; Petrini, Mario | |
| ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOLLOWING A NON-MYELOABLATIVE (NMST) CONDITIONING WITH FLUDARABINE AND LOW DOSE TBI IN PATIENTS WITH HEMATOLOCICAL MALIGNANCIES AND METASTATIC MELANOMA: A SINGLE-CENTER EXPERIENCE. | 1-gen-2004 | Benedetti, E; Papineschi, Federico; Caracciolo, F; Galimberti, Sara; Azzarà, A; Carulli, Giovanni; Petrini, Mario | |
| Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with Imatinib | 1-gen-2004 | Cervetti, G; Galimberti, Sara; Fazzi, R; Papineschi, Federico; Azzara', Antonio; Simi, P; Petrini, Mario | |
| A myeloablative allograft after rejection of two consecutive nonmyeloablative transplants from two different HLA identical siblings | 1-gen-2004 | Papineschi, Federico; Benedetti, E; Galimberti, Sara; Caracciolo, F; Fazzi, R; Petrini, Mario | |
| Infliximab treatment of grade IV skin acute graft versus host disease | 1-gen-2005 | Benedetti, E; Papineschi, Federico; Caracciolo, F; Carulli, Giovanni; Azzara', Antonio; Buda, G; Petrini, Mario | |
| GAMMA-DELTA T-LYMPHOCYTE SPECIFIC CLONES ARE INVOLVED IN THE GRAFT-VERSUS-MYELOMA AND IN THE GRAFT-VERSUS-HOST DISEASE IN MULTIPLE MYELOMA PATIENTS AFTER NON-MYELOABLATIVE TRANSPLANTATION. | 1-gen-2005 | Galimberti, Sara; Benedetti, E; Morabito, F; Battolla, B; Petrini, Iacopo; Papineschi, Federico; Martino, M; Console, G; Iacopino, P; Petrini, Mario | |
| In Vivo Purging with Hyper-CVAD Plus Rituximab Followed by Autologous Stem Cells Transplant and Rituximab Maintenance in Newly Diagnosed Mantle Cell Lymphoma: A Pilot Study for GISL (Italian Cooperative Study Group for Lymphoma). | 1-gen-2005 | Benedetti, E; Caracciolo, F; Galimberti, Sara; Papineschi, Federico; Pelosini, M; Cervetti, G; Castiglioni, Mg; Mechelli, S; Scatena, P; Brugiatelli, M; Petrini, Mario | |
| Gentuzumab ozogamicin plus Flang (My-Flang) in refractory/relapsed acute myeloid leukaemias patients and pre-allogenic stem cell transplant | 1-gen-2005 | Benedetti, E; Caracciolo, F; Papineschi, Federico; Pelosini, M; Andreazzoli, F; Azzara', Antonio; Carulli, Giovanni; Petrini, Mario | |
| Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life | 1-gen-2005 | Saccardi, R; Mancardi, Gl; Solari, A; Bosi, A; Bruzzi, P; DI BARTOLOMEO, P; Donelli, A; Filippi, M; Guerrasio, A; Gualandi, F; LA NASA, G; Murialdo, A; Pagliai, F; Papineschi, Federico; Scappini, B; Marmont, Am | |
| IN VIVO PURGING WITH HYPER-CAVD PLUS RITUXIMAB FOLLOWED BY AUTOLOGOUS TRANSPLANTATION AND RITUXIMAB MAINTENANCE IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA. | 1-gen-2005 | Benedetti, E; Caracciolo, F; Papineschi, Federico; Galimberti, Sara; Pelosini, M; Castiglioni, Mg; Mechelli, S; Scatena, P; Petrini, Mario | |
| Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation | 1-gen-2005 | Galimberti, Sara; Benedetti, E; Morabito, F; Papineschi, Federico; Callea, V; Fazzi, R; Stelitano, C; Andreazzoli, F; Guerrini, Francesca; Ciabatti, Elena; Martino, M; Nobile, F; Iacopino, P; Petrini, Mario | |
| Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications | 1-gen-2005 | Bonadio, M; Morelli, Girolamo; Mori, S; Riccioni, R; Papineschi, Federico; Petrini, Mario | |
| Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation | 1-gen-2006 | Galimberti, Sara; Benedetti, E; Morabito, F; Petrini, Iacopo; Battolla, B; Papineschi, Federico; Fazzi, R; Ciabatti, Elena; Martino, M; Cuzzola, M; Console, G; Iacopino, P; Petrini, Mario | |
| Simultaneous appearance of acute myeloid leukemia in a patient with bilateral primary uveal melanoma | 1-gen-2006 | Buda, Gabriele; Romagnoli, Mc; Galimberti, Sara; Figus, M; Papineschi, Federico; Nardi, Marco; Petrini, Mario | |
| Granulocytic sarcoma and subsequent acute leukemia recurrence with different biologic characteristics 5 years after allogeneic bone marrow transplantation for acute myeloid leukemia | 1-gen-2006 | Pelosini, M; Benedetti, E; Galimberti, Sara; Caracciolo, F; Petrini, Mario; Fazzi, R; Andreazzoli, F; Papineschi, Federico | |
| Central nervous system graft-versus-host disease: consider progressive multifocal leukoencephalopathy among the differential diagnoses | 1-gen-2007 | Focosi, D; Kast, Re; Maggi, F; Galimberti, Sara; Papineschi, Federico; Petrini, Mario; CECCHERINI-NELLI, Luca | |
| Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemia | 1-gen-2007 | Buda, G; Orciuolo, E; Galimberti, Sara; Benedetti, E; Caracciolo, F; Cervetti, G; Carulli, Giovanni; Papineschi, Federico; Petrini, Mario | |
| EFFICACY OF FLUDARABINE, CYCLOPHOSPHAMIDE, RITUXIMAB (FCR) REGIMEN FOL- LOWED BY ALEMTUZUMAB AS IN VIVO PURGING TOOL FOR PATIENTS WITH ADVANCED CHRONIC LYMPHOCYTIC LEUKEMIA | 1-gen-2007 | Galimberti, Sara; Cecconi, N; Cervetti, G; Caracciolo, F; Benedetti, E; Pelosini, M; Buda, G; Orciuolo, E; Papineschi, Federico; Petrini, Mario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile